Year: 2020
Type: article
Abstract: To date, the only treatment for celiac disease (CD) consists of following a strict gluten-free diet (GFD), which involves numerous limitations in celiac patients. For this reason, dietary transgressions are frequent, implying intestinal damage and possible long-term important complications. There is unquestionable need for GFD alternatives to avoid the damage induced by involuntary contamination or voluntary dietary transgressions. In recent years, different therapies and treatments for CD have been developed and studied based on the degradation of gluten in the intestinal lumen, the regulation of the immune response, the modulation of intestinal permeability and the induction of immunological tolerance. In this review, therapeutic lines for CD are evaluated with special emphasis on those with phase I and II clinical trials, some of them with promising results.
Language: Spanish
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3206797074
